Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · N970012/S211

AMS 700 Inflatable Penile Prosthesis (IPP) with and without InhibiZone

Boston Scientific Corp · Decision date May 18, 2026

FDA DECISIONN970012/S211

What did the FDA approve?

FDA records N970012/S211 as a supplement to PMA null, with the supplement type “Real-Time Process”. The recorded decision is approval, dated May 18, 2026.

FDA approval order statement

Approval for the design change to the TENACIO pump control valve.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Gastroenterology, Urology
Decision date
May 18, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
N970012/S211
Regulatory pathway
PMA supplement
Product code
JCW
Decision code
APPR
Decision date
May 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, penis, inflatable.

Product code
JCW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. N970012/S211 received

    Application receipt date recorded by FDA.

  2. N970012/S211 · FDA decision

    Real-Time Process

Related devices and submissions

Explore the linked device profile

Other records with product code JCW

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA supplementSep 14, 2026FDA
Boston Scientific CorpPMA supplementOct 2, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
100 Boston Scientific Way, Marlboro, MA, 01752

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records